Development and characterization of sustained release microspheres by quasi emulsion solvent diffusion method

International Journal of ChemTech Research

Volumn 1, Issue 3, 2009, Pages 634-642

  Deore, B V ^a   Mahajan, H S ^a   Deore, U V ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Aerosil; Eudragit; Ketoprofen; Microsphere; Release rate; Solvent diffusion

Indexed keywords

AEROSIL; EUDRAGIT RS; KETOPROFEN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; MICROEMULSION; PARTICLE SIZE; SUSTAINED DRUG RELEASE; TABLET FORMULATION; X RAY DIFFRACTION;

EID: 77953466009     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tsaia Y.H., Wua P.C., Huanga Y.B., Changa J.S., Tsaib M.J., Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit, Eur. J. Pharm. Biopharm., 2003,115-122.
2. Choi H.K., Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method, Int. J. Pharm. 2005, 295-303.
3. Dortun B., Haznedar S., Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide, Int. J. Pharm. 2004, 131-140.
4. Sa B., Studies on in vitro release behavior of Indomethacin loaded polystyrene microspheres, Int. J. Pharm 2000, 201,187-197.
5. Habib M.J. and Mesue R., Development of controlled release formulations of ketoprofen for oral use, Drug Dev. Ind. Pharm, 1995, 21, 1463-1472.
6. Khan M.A., Dib J. and Reddy I.K., Statistical optimization of ketoprofen-eudragit S 100 coprecipitates to obtain controlled release tablets, Drug Dev. Ind. Pharm., 1996, 22, 135-141.
7. Parejo C., Gallardo A. and San Roman J., Controlled release of NSAIDs bound to polyacrylic carrier systems, J. Mater. Sci. Mater. Med., 1998, 9, 803-809.
8. Kawashima Y., Iwamoto T., Niwa T., Takeuchi H. and Hino T., Role of the solvent-diffusion-rate modifier in a new emulsion solvent diffusion method for preparation of ketoprofen microspheres. J. Microencapsulation, 1993, 10, 329-340.
9. Giunchedi P., Conti B., Maggi L. and Conte U., Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. J. Microencapsulation, 1994,11, 381-393.
10. Orienti I., Gianasi E., Zecchi V., Conte U., Release of ketoprofen from microspheres of poly(2-hydroxyethyl methacrylate) or poly(2-hydroxyethyl methacrylate)-co- methacryloyloxyethyl deoxycholate crosslinked with ethyleneglycol dimethacrylate and tetraethylene glycol dimethacrylate, Eur. J. Pharm. Biopharm.,1995, 41, 247-253.
11. Pongpaibul Y., Price J.C. and Whitworth C.W., Preparation and evaluation of controlled-release indomethacin microspheres, Drug. Dev. Ind. Pharm., 1984, 10, 1597-1616.
12. Benita S., Hoffman A. and Donbrow M., Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model, J. Pharm. Pharmacol., 1985,37, 391-395.
13. Cui F.D., Kawashima Y., Takeuchi H., Niwa T. and Hino T., Preparation of controlled releasing acrylic polymer microspheres of acebutolol hydrochloride and those powder coated microspheres with sodium alginate in a polymeric spherical crystallization system, Chem. Pharm. Bull., 1996,44, 837-842.
14. Sheth A. and Jarowski C.I., Use of powdered solutions to improve the dissolution rate of polythiazide tablets, Drug Dev.Ind. Pharm., 1990, 16, 769-777.
15. Bayomi M., Aqueous preparation and evaluation of albumin chitosan microspheres containing Indomethacin, Drug Dev. Ind. Pharm., 2004, 30(4), 329-339.
16. Yang M.S., Cui F., Wang L. Preparation of sustained release microspheres with Eudragit RS and Aerosil using quasi emulsion solvent diffusion method, Int. J. Pharm., 2003, 103-113.
17. Perumal D. Microencapsulation of Ibuprofen and Eudragit RS100 by the emulsion solvent diffusion technique, Int. J. Pharm. 2001, 1-11.
18. Cui F., Preparation of sustained-release nitrendipine microspheres with eudragit RS and aerosil using quasi emulsion solvent diffusion method, Int. J. Pharm. 2003,103-113.
19. Gibaud S., Alain A., Poly (ε-caprolactone) and Eudragit microparticles containing fludrocortisone acetate, Int. J. Pharm. 2004, 269,491-508.
20. Cui F., Preparation of roxithromycin polymeric microspheres by the emulsion solvent diffusion method for taste masking, Int. J. Pharm., 2006, 318,62-69.
21. Haznedar S., Dortun B., Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide, Int. J. Pharm, 2004,131-140.
22. Watts P., Wilson C., Davies M., Melia C.D., A pharmacoscintigraphic study of colon-targeted Eudragit RS-sulphapyridine microspheres in human volunteers, Int. J. Pharm. 1994, 102,101-108.
23. Kristmundsd T., Gudmundsson O.S., Ingvarsdottir K., Release of diltiazem from eudragit microparticles prepared by spray-drying, Int. J. Pharm., 1996, 37, 159-165.
24. Perumal D., Microencapsulation of ibuprofen and eudragit RS100 by the emulsion solvent diffusion technique, Int. J. Pharm., 2001,1-11.
25. Tsaib M.J., Tsaia Y.H., Wua P.C., Huanga Y.B., Changa J.S., Design and evaluation of sustained release microspheres of potassium chloride prepared by eudragit, Eur. J Pharm. Biopharm., 2003,115-122.
26. Handa T., Niva T., Preparation of controlled released microspheres of ibuprofen with acrylic polymers by a novel quasi emulsion solvent diffusion method, J. Pharm. Sci., 1989, 78, 68-72.